(Q87652766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Elisabeth de Vries

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Urszula M Domanska

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Hetty Timmer-Bosscha

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Marcel A T M van Vugt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Hilde D Hoving

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Nathalie M Kliphuis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Stefano Rosati

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Henk G van der Poel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Igle Jan de Jong

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Annemiek M E Walenkamp

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

26 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Metastasis

13 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

829-839

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis

13 March 2020

cites work

1 reference

12 December 2020

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

1 reference

12 December 2020

Neutralizing tumor-promoting chronic inflammation: a magic bullet?

1 reference

12 December 2020

CXCR4 regulates growth of both primary and metastatic breast cancer

1 reference

12 December 2020

Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth

1 reference

12 December 2020

AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice.

1 reference

12 December 2020

CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion

1 reference

12 December 2020

Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.

1 reference

12 December 2020

Neovascularization after irradiation: what is the source of newly formed vessels in recurring tumors?

1 reference

12 December 2020

Environment-mediated drug resistance: a major contributor to minimal residual disease

1 reference

12 December 2020

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

1 reference

12 December 2020

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

1 reference

12 December 2020

1 reference

12 December 2020

Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy

1 reference

12 December 2020

Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines

1 reference

12 December 2020

A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer

1 reference

12 December 2020

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

1 reference

12 December 2020

Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases

1 reference

12 December 2020

AMD3100 is a CXCR7 ligand with allosteric agonist properties

1 reference

12 December 2020

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

1 reference

12 December 2020

G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

1 reference

12 December 2020

Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo

1 reference

12 December 2020

Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation

1 reference

12 December 2020

The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance

1 reference

12 December 2020

Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer

1 reference

12 December 2020

Involvement of chemokine receptors in breast cancer metastasis

1 reference

12 December 2020

Combined blockade of integrin-α4β1 plus cytokines SDF-1α or IL-1β potently inhibits tumor inflammation and growth

1 reference

12 December 2020

Characterization of two mouse models of metastatic pheochromocytoma using bioluminescence imaging

1 reference

12 December 2020

Microenvironment and radiation therapy

1 reference

12 December 2020

Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.

1 reference

12 December 2020

CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy

1 reference

12 December 2020

Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib

1 reference

12 December 2020

CXCL12 receptor preference, signal transduction, biological response and the expression of 5T4 oncofoetal glycoprotein

1 reference

12 December 2020

The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression

1 reference

12 December 2020

Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function

1 reference

12 December 2020

CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model

1 reference

12 December 2020

Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis

1 reference

12 December 2020

Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow

1 reference

12 December 2020

Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis

1 reference

12 December 2020

A phase I trial of LY2510924, a CXCR4 peptide antagonist, in patients with advanced cancer

1 reference

12 December 2020

CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.

1 reference

12 December 2020

Radiation and the microenvironment - tumorigenesis and therapy

1 reference

12 December 2020

Molecular pathways: emerging pathways mediating growth, invasion, and metastasis of tumors progressing in an irradiated microenvironment.

1 reference

12 December 2020

Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone

1 reference

12 December 2020

10.1007/S10585-014-9673-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25154297%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference